1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson’s disease mouse model
(
- Contribution to journal › Article
-
Mark
Association between Parkinson’s Disease and Diabetes Mellitus : From Epidemiology, Pathophysiology and Prevention to Treatment
(
- Contribution to journal › Article
- 2020
-
Mark
No symphony without bassoon and piccolo : Changes in synaptic active zone proteins in Huntington's disease
(
- Contribution to journal › Article
- 2019
-
Mark
Gut Inflammation in Association With Pathogenesis of Parkinson’s Disease
(
- Contribution to journal › Scientific review
-
Mark
Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy
(
- Contribution to journal › Article
-
Mark
Microbiome changes : an indicator of Parkinson's disease?
(
- Contribution to journal › Scientific review
- 2016
-
Mark
Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain.
2016) In Proceedings of the National Academy of Sciences of the United States of America 113(23). p.6544-6549(
- Contribution to journal › Article
- 2013
-
Mark
Axonopathy in Huntington's disease.
(
- Contribution to journal › Scientific review
- 2011
-
Mark
Signs of Degeneration in 12-22-Year Old Grafts of Mesencephalic Dopamine Neurons in Patients with Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
IGF-1 protects against diabetic features in an in vivo model of Huntington's disease.
(
- Contribution to journal › Article